HM Payson & Co’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6K Sell
75
-100
-57% -$2.68K ﹤0.01% 1033
2026
Q1
$3.63K Buy
175
+100
+133% +$2.36K ﹤0.01% 998
2025
Q4
$2.44K Hold
75
﹤0.01% 1036
2025
Q3
$4.25K Hold
75
﹤0.01% 960
2025
Q2
$3.74K Buy
75
+15
+25% +$678 ﹤0.01% 896
2025
Q1
$1.77K Buy
+60
New +$2.23K ﹤0.01% 969

Other funds holding HIMS

HM Payson & Co's HIMS Position: Q2 2026 in Review

HM Payson & Co reduced its Hims & Hers Health (HIMS) stake by 57% in Q2 2026, selling an estimated $2.68K and leaving 75 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

HM Payson & Co first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.25K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • HM Payson & Co held 75 shares of Hims & Hers Health worth $2.6K as of Q2 2026.
  • HM Payson & Co sold 100 Hims & Hers Health shares in Q2 2026, an estimated $2.68K.
  • Hims & Hers Health made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1033 holding.
  • HM Payson & Co first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
  • HM Payson & Co's Hims & Hers Health position peaked at $4.25K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.